Koninklijke Philips (NYSE:PHG – Get Rating) – Research analysts at Jefferies Financial Group dropped their FY2022 earnings per share estimates for shares of Koninklijke Philips in a report issued on Tuesday, July 26th. Jefferies Financial Group analyst J. Vane-Tempest now forecasts that the technology company will earn $1.26 per share for the year, down from their previous estimate of $1.66. The consensus estimate for Koninklijke Philips’ current full-year earnings is $1.67 per share. Jefferies Financial Group also issued estimates for Koninklijke Philips’ FY2023 earnings at $1.59 EPS.
Several other brokerages also recently weighed in on PHG. UBS Group cut their price target on Koninklijke Philips from €17.00 ($17.35) to €16.00 ($16.33) and set a “sell” rating on the stock in a research report on Tuesday. JPMorgan Chase & Co. cut their price target on Koninklijke Philips from €21.30 ($21.73) to €18.80 ($19.18) and set an “underweight” rating on the stock in a research report on Wednesday. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Koninklijke Philips from €25.00 ($25.51) to €24.00 ($24.49) and set a “hold” rating on the stock in a research note on Tuesday, July 5th. StockNews.com initiated coverage on shares of Koninklijke Philips in a research note on Thursday, March 31st. They set a “hold” rating on the stock. Finally, Barclays lowered their target price on shares of Koninklijke Philips from €45.00 ($45.92) to €39.00 ($39.80) in a research note on Thursday. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Koninklijke Philips currently has a consensus rating of “Hold” and an average target price of $25.76.
Koninklijke Philips Price Performance
NYSE PHG opened at $21.06 on Friday. The stock’s fifty day moving average price is $22.46 and its 200 day moving average price is $27.86. The company has a market cap of $18.73 billion, a price-to-earnings ratio of 5.19, a PEG ratio of 1.11 and a beta of 0.97. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.39 and a quick ratio of 0.93. Koninklijke Philips has a 1 year low of $20.05 and a 1 year high of $48.72.
Koninklijke Philips (NYSE:PHG – Get Rating) last released its earnings results on Monday, April 25th. The technology company reported $0.32 earnings per share (EPS) for the quarter. Koninklijke Philips had a return on equity of 8.41% and a net margin of 19.20%. The firm had revenue of $4.29 billion for the quarter.
Institutional Investors Weigh In On Koninklijke Philips
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. UMB Bank N A MO purchased a new stake in Koninklijke Philips in the 4th quarter valued at $46,000. SRS Capital Advisors Inc. grew its holdings in shares of Koninklijke Philips by 77.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,531 shares of the technology company’s stock worth $56,000 after purchasing an additional 666 shares during the period. Prospera Financial Services Inc purchased a new position in shares of Koninklijke Philips during the 1st quarter worth $62,000. EverSource Wealth Advisors LLC purchased a new position in shares of Koninklijke Philips during the 4th quarter worth $95,000. Finally, Emfo LLC purchased a new position in shares of Koninklijke Philips during the 2nd quarter worth $57,000. Institutional investors and hedge funds own 14.84% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Should you invest $1,000 in Koninklijke Philips right now?
Before you consider Koninklijke Philips, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Koninklijke Philips wasn’t on the list.
While Koninklijke Philips currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here